InsituGen
Dunedin
About InsituGen
InsituGen’s unique cell-free bioassays replicate the natural biological signalling pathways of estrogen and androgen receptors, detecting activity from any known or unknown compound that interferes with steroid hormone receptors. InsituGen’s bioassays and are simple to use, cost-effective, adaptable, fast, sensitive, and accurate.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $2.5M
- Funding stage: Seed
- Last round: Pre-Seed (Jul 2025)
- Website: insitugen.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Test and Measurement, Veterinary
Social Profiles
Canonical: https://fsome.com/organization/insitugen-131431 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.